Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Disseminated and Congenital Toxoplasmosis in a Mother and Child With Activated PI3-Kinase δ Syndrome Type 2 (APDS2): Case Report and a Literature Review of Toxoplasma Infections in Primary Immunodeficiencies.

Karanovic D, Michelow IC, Hayward AR, DeRavin SS, Delmonte OM, Grigg ME, Dobbs AK, Niemela JE, Stoddard J, Alhinai Z, Rybak N, Hernandez N, Pittaluga S, Rosenzweig SD, Uzel G, Notarangelo LD.

Front Immunol. 2019 Feb 14;10:77. doi: 10.3389/fimmu.2019.00077. eCollection 2019. Review.

2.

Chelator profiling in Deschampsia cespitosa (L.) Beauv. Reveals a Ni reaction, which is distinct from the ABA and cytokinin associated response to Cd.

Hayward AR, Coates KE, Galer AL, Hutchinson TC, Emery RJ.

Plant Physiol Biochem. 2013 Mar;64:84-91. doi: 10.1016/j.plaphy.2012.12.018. Epub 2013 Jan 24.

PMID:
23399533
3.

Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.

Weinberg A, Lazar AA, Zerbe GO, Hayward AR, Chan IS, Vessey R, Silber JL, MacGregor RR, Chan K, Gershon AA, Levin MJ.

J Infect Dis. 2010 Apr 1;201(7):1024-30. doi: 10.1086/651199.

4.

Immune response to a refrigerator-stable zoster vaccine.

Levin MJ, Oxman MN, Johnson GR, Zhang JH, Hayward AR, Weinberg A.

Clin Vaccine Immunol. 2009 Sep;16(9):1381; author reply 1381-2. doi: 10.1128/CVI.00338-08. No abstract available.

5.

Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

Weinberg A, Zhang JH, Oxman MN, Johnson GR, Hayward AR, Caulfield MJ, Irwin MR, Clair J, Smith JG, Stanley H, Marchese RD, Harbecke R, Williams HM, Chan IS, Arbeit RD, Gershon AA, Schödel F, Morrison VA, Kauffman CA, Straus SE, Schmader KE, Davis LE, Levin MJ; US Department of Veterans Affairs (VA) Cooperative Studies Program Shingles Prevention Study Investigators.

J Infect Dis. 2009 Oct 1;200(7):1068-77. doi: 10.1086/605611.

6.

Identification and quantification of glutathione and phytochelatins from Chlorella vulgaris by RP-HPLC ESI-MS/MS and oxygen-free extraction.

Simmons DB, Hayward AR, Hutchinson TC, Emery RJ.

Anal Bioanal Chem. 2009 Oct;395(3):809-17. doi: 10.1007/s00216-009-3016-1. Epub 2009 Aug 18.

PMID:
19688341
7.

Making clinical research a robust career path.

Hayward AR.

Acad Med. 2009 Apr;84(4):409-10. doi: 10.1097/ACM.0b013e31819a817f.

PMID:
19318765
8.

Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.

Levin MJ, Oxman MN, Zhang JH, Johnson GR, Stanley H, Hayward AR, Caulfield MJ, Irwin MR, Smith JG, Clair J, Chan IS, Williams H, Harbecke R, Marchese R, Straus SE, Gershon A, Weinberg A; Veterans Affairs Cooperative Studies Program Shingles Prevention Study Investigators.

J Infect Dis. 2008 Mar 15;197(6):825-35. doi: 10.1086/528696.

9.

Remodeling the NGVL program to meet contemporary needs.

Hayward AR.

Mol Ther. 2007 Jul;15(7):1223-4. No abstract available.

10.

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group.

N Engl J Med. 2005 Jun 2;352(22):2271-84.

11.

Clinical trials for the prevention of type 1 diabetes.

Chase HP, Hayward AR, Eisenbarth GS.

Adv Exp Med Biol. 2004;552:291-305. Review. No abstract available.

PMID:
15622969
12.

Loading of peptide on to MHC molecule is not essential for clearance of Cryptosporidium parvum.

Ponnuraj EM, Sanapareddy N, Hayward AR.

J Eukaryot Microbiol. 2003;50 Suppl:560-2.

PMID:
14736162
13.

Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine.

Levin MJ, Smith JG, Kaufhold RM, Barber D, Hayward AR, Chan CY, Chan IS, Li DJ, Wang W, Keller PM, Shaw A, Silber JL, Schlienger K, Chalikonda I, Vessey SJ, Caulfield MJ.

J Infect Dis. 2003 Nov 1;188(9):1336-44. Epub 2003 Oct 17.

PMID:
14593591
14.

Chronic varicella-zoster virus ganglionitis--a possible cause of postherpetic neuralgia.

Gilden DH, Cohrs RJ, Hayward AR, Wellish M, Mahalingam R.

J Neurovirol. 2003 Jun;9(3):404-7.

PMID:
12775423
15.

Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model.

Ponnuraj EM, Springer J, Hayward AR, Wilson H, Simoes EA.

J Infect Dis. 2003 Apr 15;187(8):1257-63. Epub 2003 Apr 2.

PMID:
12696005
16.

Measurement of cell-mediated immunity with a Varicella-Zoster Virus-specific interferon-gamma ELISPOT assay: responses in an elderly population receiving a booster immunization.

Smith JG, Levin M, Vessey R, Chan IS, Hayward AR, Liu X, Kaufhold RM, Clair J, Chalikonda I, Chan C, Bernard M, Wang WW, Keller P, Caulfield MJ.

J Med Virol. 2003;70 Suppl 1:S38-41.

PMID:
12627485
18.

Cytokine and immunosuppressive therapies of type 1 diabetes mellitus.

Gottlieb PA, Hayward AR.

Endocrinol Metab Clin North Am. 2002 Jun;31(2):477-95. Review.

PMID:
12092462
19.
21.
22.

In vitro measurement of human T cell responses to varicella zoster virus antigen.

Hayward AR.

Arch Virol Suppl. 2001;(17):143-9. Review.

PMID:
11339543
23.

Marrow-derived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection.

Hayward AR, Cosyns M, Jones M, Ponnuraj EM.

Infect Immun. 2001 Mar;69(3):1630-4.

24.

Interferon-gamma is required for innate immunity to Cryptosporidium parvum in mice.

Hayward AR, Chmura K, Cosyns M.

J Infect Dis. 2000 Sep;182(3):1001-4. Epub 2000 Aug 17.

PMID:
10950807
25.

X-linked immunodeficiency with hyper-IgM (XHIM).

Notarangelo LD, Hayward AR.

Clin Exp Immunol. 2000 Jun;120(3):399-405. Review. No abstract available.

26.

Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older.

Levine MJ, Ellison MC, Zerbe GO, Barber D, Chan C, Stinson D, Jones M, Hayward AR.

Vaccine. 2000 Jun 15;18(25):2915-20.

PMID:
10812235
27.
28.

Respiratory syncytial virus infects the Bonnet monkey, Macaca radiata.

Simoes EA, Hayward AR, Ponnuraj EM, Straumanis JP, Stenmark KR, Wilson HL, Babu PG.

Pediatr Dev Pathol. 1999 Jul-Aug;2(4):316-26.

PMID:
10347274
29.

Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect.

Levin MJ, Barber D, Goldblatt E, Jones M, LaFleur B, Chan C, Stinson D, Zerbe GO, Hayward AR.

J Infect Dis. 1998 Nov;178 Suppl 1:S109-12.

PMID:
9852987
30.

Cellular immunity to varicella-zoster virus in patients with major depression.

Irwin M, Costlow C, Williams H, Artin KH, Chan CY, Stinson DL, Levin MJ, Hayward AR, Oxman MN.

J Infect Dis. 1998 Nov;178 Suppl 1:S104-8. Erratum in: J Infect Dis 1999 Mar;179(3):753.

PMID:
9852986
31.

Cytokine production in varicella-zoster virus-stimulated cultures of human blood lymphocytes.

Hayward AR, Cosyns M, Jones M, Levin MJ, Villanueba E, Weinberg A, Chan CY.

J Infect Dis. 1998 Nov;178 Suppl 1:S95-8.

PMID:
9852984
32.

Requirement of CD40-CD40 ligand interaction for elimination of Cryptosporidium parvum from mice.

Cosyns M, Tsirkin S, Jones M, Flavell R, Kikutani H, Hayward AR.

Infect Immun. 1998 Feb;66(2):603-7.

33.

Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM.

Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A.

J Immunol. 1997 Jan 15;158(2):977-83.

PMID:
8993019
34.

The varicella vaccine. Prevention of herpes zoster.

Levin MJ, Hayward AR.

Infect Dis Clin North Am. 1996 Sep;10(3):657-75. Review.

PMID:
8856358
35.

Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity.

Weinberg A, Hayward AR, Masters HB, Ogu IA, Levin MJ.

J Clin Microbiol. 1996 Feb;34(2):445-6.

36.

Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine.

Hayward AR, Buda K, Jones M, White CJ, Levin MJ.

Viral Immunol. 1996;9(4):241-5.

PMID:
8978020
37.

Immune response to varicella-zoster virus 5 years after acyclovir therapy of childhood varicella.

Levin MJ, Rotbart HA, Hayward AR.

J Infect Dis. 1995 May;171(5):1383-4. No abstract available.

PMID:
7751725
38.
39.

Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures.

Zhang Y, Cosyns M, Levin MJ, Hayward AR.

Clin Exp Immunol. 1994 Oct;98(1):128-33.

40.

Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine.

Levin MJ, Murray M, Zerbe GO, White CJ, Hayward AR.

J Infect Dis. 1994 Sep;170(3):522-6.

PMID:
8077709
41.

Acyclovir-resistant neonatal herpes simplex virus infection of the larynx.

Nyquist AC, Rotbart HA, Cotton M, Robinson C, Weinberg A, Hayward AR, Berens RL, Levin MJ.

J Pediatr. 1994 Jun;124(6):967-71.

PMID:
8201488
42.

Clinical application of responder cell frequency estimates with four years of follow up.

Hayward AR, Zerbe GO, Levin MJ.

J Immunol Methods. 1994 Mar 29;170(1):27-36.

PMID:
8157986
43.

Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infection.

Byars NE, Fraser-Smith EB, Pecyk RA, Welch M, Nakano G, Burke RL, Hayward AR, Allison AC.

Vaccine. 1994;12(3):200-9.

PMID:
8165851
44.
45.

Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4.

Hayward AR, Shriber M, Cooke A, Waldmann H.

J Autoimmun. 1993 Jun;6(3):301-10.

PMID:
8104407
46.

Degeneration of aortic valve allografts in young recipients.

Clarke DR, Campbell DN, Hayward AR, Bishop DA.

J Thorac Cardiovasc Surg. 1993 May;105(5):934-41; discussion 941-2.

PMID:
8487572
47.

Immune responses to varicella zoster virus infections in healthy children.

Rotbart HA, Levin MJ, Hayward AR.

J Infect Dis. 1993 Jan;167(1):195-9.

PMID:
8380291
48.

Herpes simplex virus interferes with monocyte accessory cell function.

Hayward AR, Read GS, Cosyns M.

J Immunol. 1993 Jan 1;150(1):190-6.

PMID:
8380188
49.

Immune response of elderly individuals to a live attenuated varicella vaccine.

Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR.

J Infect Dis. 1992 Aug;166(2):253-9.

PMID:
1321859
50.

Vitamin E supplementation reduces the incidence of diabetes but not insulitis in NOD mice.

Hayward AR, Shriber M, Sokol R.

J Lab Clin Med. 1992 May;119(5):503-7.

PMID:
1583406

Supplemental Content

Loading ...
Support Center